Elsevier

International Journal of Cardiology

Volume 244, 1 October 2017, Pages 271-276
International Journal of Cardiology

Inter-arm systolic blood pressure differences, relations with future vascular events and mortality in patients with and without manifest vascular disease

https://doi.org/10.1016/j.ijcard.2017.06.044Get rights and content

Abstract

Background

Inter-arm systolic blood pressure difference (SBPD) is an easily obtained patient characteristic which relates to vascular disease. We aimed to identify determinants of large inter-arm SBPD and to investigate the relation between inter-arm SBPD and vascular events in patients with and without manifest vascular disease.

Methods

In a cohort of 7344 patients with manifest vascular disease or vascular risk factors alone enrolled in the Second Manifestations of ARTerial disease (SMART) study, single bilateral non-simultaneous blood pressure measurements were performed. Logistic and Cox regression was used to identify determinants of large inter-arm SBPD (≥ 15 mm Hg) and to investigate the relation between inter-arm SBPD and vascular events (composite of non-fatal myocardial infarction, stroke, and vascular mortality) and all-cause mortality.

Results

In all patients the median inter-arm SBPD was 7 mm Hg (IQR 3–11) and 1182 (16%) patients had inter-arm SBPD ≥ 15 mm Hg. Higher age, higher systolic blood pressure, diabetes mellitus, peripheral artery disease, carotid artery stenosis, higher carotid intima-media thickness, and lower ankle-brachial indices were related to large inter-arm SBPD (≥ 15 mm Hg). Each 5 mm Hg increase in inter-arm SBPD was related to a 12% higher risk of vascular events in patients without manifest vascular disease (HR 1.12; 95% CI 1.00–1.27), whereas no relation was apparent in patients with manifest vascular disease (HR 0.98; 95% CI 0.93–1.04, interaction p-value 0.036). Inter-arm SBPD was not related to all-cause mortality (HR 1.05; 95% CI 0.93–1.19).

Conclusions

Inter-arm SBPD relates to a higher risk of vascular events in patients without manifest vascular disease, whereas this relation is not apparent in patients with manifest vascular disease.

Introduction

Peripheral artery disease (PAD) significantly contributes to the total burden of vascular disease as it is related to high risks of vascular morbidity and mortality [1], [2]. Although PAD most often presents as an atherosclerotic disease of the leg arteries, atherosclerotic changes in the arteries of the upper limbs occur as well [3]. Inter-arm systolic blood pressure difference (SBPD) reflects subclavian stenosis which in most cases is caused by atherosclerosis in the upper limb arteries [4]. In rare cases there may be another origin such as arteritis, fibromuscular dysplasia, arterial injuries or arterial dissection [5], [6], [7]. International hypertension guidelines stress the importance of bilateral blood pressure measurement and state that large inter-arm SBPD is an indicator of elevated vascular risk [8], [9]. Indeed, high inter-arm SBPD (> 15 mm Hg) relates to an approximately 1.6-fold risk of cardiovascular mortality [4], [10]. Although the association of inter-arm SBPD with atherosclerotic stenosis of the upper arm arteries is generally acknowledged, little is known about the precise determinants of a large inter-arm SBPD.

Several epidemiological studies indicate that large inter-arm SBPD confers a higher risk for (cardiovascular) mortality and relates to the presence of cardiovascular risk factors, PAD of the lower extremities, and cerebrovascular disease [4], [10], [11], [12], [13], [14]. Previous studies mostly used cut off values (≥ 10, ≥ 15 or ≥ 20 mm Hg) to investigate the relation between inter-arm SBPD and prevalent vascular disease, while a continuous approach could provide more precise information [10], [11]. A small prospective cohort study of 230 patients with hypertension with a median follow-up of 9.8 years shows that each 1 mm Hg increase in inter-arm SBPD relates to future cardiovascular events (HR 1.04; 95% CI 1.02–1.07) [15]. Also, a larger community-based prospective cohort including 3390 participants shows that each standard deviation increase in inter-arm SBPD relates to cardiovascular events (HR 1.07; 95% CI 1.00–1.14) [14]. Nevertheless, evidence on the relation in patients with manifestations of vascular disease is scarce [10], [11].

The presence of clinical manifest vascular disease might influence the relation between inter-arm SBPD and vascular events. Patients with clinical manifest vascular disease are at higher risk for vascular events than patients without clinical manifestations of vascular disease. Therefore the relation between inter-arm SBPD and vascular risk might be different in patients with and without clinical manifest vascular disease.

The aim of the present study is to identify determinants of high inter-arm SBPD and to investigate the relation between inter-arm SBPD and vascular events and all-cause mortality in patients with and without clinical manifest vascular disease.

Section snippets

Study population

Data of 7344 participants enrolled in the Second Manifestations of ARTerial disease (SMART) study after the first of January 2002 and before the first of March 2014 were used for this study. The SMART study is an ongoing prospective single-center cohort study in the University Medical Center Utrecht (UMCU), The Netherlands. Patients with manifest vascular disease (coronary artery disease, cerebrovascular disease, peripheral artery disease or abdominal aortic aneurysm) and patients without

Results

Table 1 summarizes the baseline characteristics. In patients with manifest vascular disease (n = 5293) the mean age was 60 years (± 10) and 73% of the participants were male. In patients without manifest vascular disease (n = 2051) the mean age was 50 years (± 13) and 52% of the participants were male.

Discussion

In our study in patients with and without clinical manifest vascular disease 16% had a large inter-arm SBPD (≥ 15 mm Hg). Determinants of large inter-arm differences were age, SBP, diabetes mellitus, carotid stenosis ≥ 70%, carotid intima-media thickness, and lower ankle-brachial indexes. In patients without clinical manifest vascular disease each 5 mm Hg increase in inter-arm SBPD is significantly related to a 12% higher risk of vascular events, whereas in patients with manifest vascular disease no

Conflict of interest statement

None.

Acknowledgements

We gratefully acknowledge the SMART research nurses; R. van Petersen (data-manager); B.G.F. Dinther (vascular manager) and the participants of the SMART Study Group: A. Algra MD, PhD; Y. van der Graaf, MD,PhD; D.E. Grobbee, MD, PhD; G.E.H.M. Rutten, MD, PhD, Julius Center for Health Sciences and Primary care; F.L.J. Visseren, MD, PhD, Department of Internal Medicine; G.J. de Borst, MD, PhD, Department of Vascular Surgery; L.J. Kappelle, MD, PhD, Department of Neurology; T. Leiner, MD, PhD,

References (40)

  • D. Mozaffarian et al.

    Heart disease and stroke statistics-2015 update: a report from the American Heart Association

    Circulation

    (2014)
  • C.E. Clark et al.

    Prevalence and clinical implications of the inter-arm blood pressure difference: a systematic review

    J. Hum. Hypertens.

    (2006)
  • J.R. Durham et al.

    Arterial injuries in the thoracic outlet syndrome

    J. Vasc. Surg.

    (1995)
  • H. Jaques

    NICE guideline on hypertension

    Eur. Heart J.

    (2013)
  • G. Mancia et al.

    2013 ESH/ESC practice guidelines for the management of arterial hypertension

    Blood Press.

    (2014)
  • C.E. Clark et al.

    Interarm blood pressure difference in people with diabetes: measurement and vascular and mortality implications: a cohort study

    Diabetes Care

    (2014)
  • J. Kim et al.

    Interarm blood pressure difference and mortality in patients with acute ischemic stroke

    Neurology

    (2013)
  • C.E. Clark et al.

    The difference in blood pressure readings between arms and survival: primary care cohort study

    BMJ

    (2012)
  • P.C. Simons et al.

    Second Manifestations of ARTerial disease (SMART) study: rationale and design

    Eur. J. Epidemiol.

    (1999)
  • W.T. Friedewald et al.

    Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

    Clin. Chem.

    (1972)
  • Cited by (0)

    View full text